Advertisement

Obesity Surgery

, Volume 26, Issue 12, pp 3011–3013 | Cite as

Reply to the Comment on: “Prediction of Diabetes Remission in Morbidly Obese Patients After Roux-en-Y Gastric Bypass”

  • Ji Yeon Park
  • Yong Jin Kim
Letter to Editor/LED Reply

Reply to a Letter to the Editor:

A Letter to the Editor regarding our previous study entitled “Prediction of diabetes remission in morbidly obese patients after Roux-en-Y gastric bypass” was submitted by an anonymous author, possibly from a Taiwanese study group as revealed from the context of the letter [1]. We appreciate the author’s interest and comments regarding our results.

Since the author suggested the idea of validating the efficacy of the ABCD score and the DiaRem score with our own study cohort, we would like to describe the data for these two preoperative scoring systems to evaluate the predictability of diabetes remission in our cohort.

As described in our original publication, we defined complete remission and partial remission as an HbA1c level of <6.0 and <6.5 % without any antidiabetic medications, respectively. The scoring systems were adopted from the previously published studies by Still CD et al. (the DiaRem score) and Lee WJ et al. (the modified ABCD score) [2, 3]...

Keywords

Metformin Gastric Bypass HbA1c Level Score Group Antidiabetic Medication 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgments

Min Ju Soh, a research coordinator, contributed to this manuscript by collecting data for the analyses.

Compliance with ethical standards

Conflict of Interest

The authors declare that they have no conflict of interest.

Ethical Approval

For this type of retrospective study, formal consent is not required.

Informed Consent

This does not apply to this retrospective study.

References

  1. 1.
    Park JY, Kim YJ. Prediction of diabetes remission in morbidly obese patients after Roux-en-Y gastric bypass. Obes Surg. 2016;26(4):749–56. Epub 2015/07/25.CrossRefPubMedGoogle Scholar
  2. 2.
    Still CD, Wood GC, Benotti P, et al. Preoperative prediction of type 2 diabetes remission after Roux-en-Y gastric bypass surgery: a retrospective cohort study. Lancet Diabetes Endocrinol. 2014;2(1):38–45. Epub 2014/03/01.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Lee WJ, Almulaifi A, Chong K, et al. The effect and predictive score of gastric bypass and sleeve gastrectomy on type 2 diabetes mellitus patients with BMI < 30 kg/m(2). Obes Surg. 2015;25(10):1772–8. Epub 2015/02/14.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  1. 1.Department of SurgeryKyungpook National University Medical CenterDaeguRepublic of Korea
  2. 2.Department of surgerySoonchunhyang University Seoul hospitalSeoulRepublic of Korea

Personalised recommendations